- $26.27m
- $39.77m
- $65.27m
Brief: Cosmos Health Secures Additional 2.5 Mln Units Under New Five-Year Contract Manufacturing Deal With Viofar
Brief: Cosmos Health Reaffirms 2029 Guidance
Brief: Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Deal With Innova Healthcare
Brief: Cosmos Health Reports Q2 2026
Brief: Cosmos Health Q2 Gross Profit USD 1.51 Million
Cosmos Health Inc expected to post earnings of 1 cent a share - Earnings Preview
Brief: Cosmos Health Share Buyback Expands To 5.11 Million Shares
Brief: Cosmos Health Share Buyback Expands To 4.49 Million Shares, Continues Open Market Repurchases
Brief: Cosmos Health Enters Five-Year Agreement For DIABIT-IS X In Greece
Brief: Cosmos Health Launches Subscription-Based Purchasing Model For Consumer Health Brands
Cosmos Health posts record preliminary Q2 revenue
Brief: Cosmos Health Share Buyback Increases To 3.64 Million Shares, Continues Open Market Purchases
Brief: Cosmos Health Expands Buyback To 3.42 Mln Shares, Continues Open Market Purchases
Brief: Cosmos Health Authorizes Up To $5 Million Share Repurchase Program
Brief: Cosmos Health Enters Five-Year Contract Manufacturing Agreement With Pharmex
Brief: Cosmos Health Secures Additional 180-Day Nasdaq Extension To Regain Bid Price Compliance
Brief: Cosmos Health Targets $200 Mln Revenue, $44 Mln Adjusted EBITDA By 2029
Cosmos Health Q1 revenue rises to record
Brief: Cosmos Health Q1 Revenue USD 17.9 Million